9-128624367-G-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4BS1_SupportingBS2
The NM_001130438.3(SPTAN1):c.5872G>T(p.Gly1958Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000105 in 1,613,836 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001130438.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152080Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251246Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135836
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461756Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727168
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152080Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74298
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.5872G>T (p.G1958C) alteration is located in exon 46 (coding exon 45) of the SPTAN1 gene. This alteration results from a G to T substitution at nucleotide position 5872, causing the glycine (G) at amino acid position 1958 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Early infantile epileptic encephalopathy with suppression bursts Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with cysteine, which is neutral and slightly polar, at codon 1958 of the SPTAN1 protein (p.Gly1958Cys). This variant is present in population databases (no rsID available, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with SPTAN1-related conditions. ClinVar contains an entry for this variant (Variation ID: 411798). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Not Available". The cysteine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Developmental and epileptic encephalopathy, 5 Uncertain:1
This variant has not been reported in the literature but is present in 0.02% (9/41396) of African alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/9 128624367 G T?dataset=gnomad_r3). This variant is present in ClinVar (Variation ID:411798). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at